Transient Ischemic Attack: Review for the Emergency Physician

Annals of Emergency Medicine

Volumn 43, Issue 5, 2004, Pages 592-604

  Shah, Kaushal H ^a   Edlow, Jonathan A ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; TICLOPIDINE; WARFARIN;

BLEEDING; DIARRHEA; EMERGENCY MEDICINE; EMERGENCY WARD; GASTROINTESTINAL HEMORRHAGE; HEART INFARCTION; HUMAN; NEUTROPENIA; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; REVIEW; STROKE; THROMBOCYTOPENIC PURPURA; TRANSIENT ISCHEMIC ATTACK;

EID: 2342425118     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2003.12.025     Document Type: Review

References (81)

1. Feinberg WM. Guidelines for the management of transient ischemic attacks: Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council, American Heart Association. Heart Dis Stroke. 1994;3:275-283.
2. Johnston SC, Gress DR, Browner WS, et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901-2906.
3. Lovett JK, Dennis MS, Sandercock PA, et al. Very early risk of stroke after a first transient ischemic attack. Stroke. 2003;34:e138-140.
4. Johnston SC, Fayad PB, Gorelick PB, et al. Prevalence and knowledge of transient ischemic attack among US adults. Neurology. 2003;60:1429-1434.
5. Goldstein LB, Bian J, Samsa GP, et al. New transient ischemic attack and stroke: outpatient management by primary care physicians. Arch Intern Med. 2000;160:2941-2946.
6. Grisolia JS, Lobatz M. Medicolegal neurology: Special issues. eMedicine [serial online]. Available at: http://www.emedicine.com/neuro/topic651.htm. Accessed March 24, 2004.
7. Albers GW, Caplan LR, Coull BM. Transient ischemic attack: proposal for a new definition. N Engl J Med. 2002;347:1713-1716.
8. Ay H, Oliveira-Filho J, Buonanno FS, et al. 'Footprints' of transient ischemic attacks: a diffusion-weighted MRI study. Cerebrovasc Dis. 2002;14:177-186.
9. Kidwell CS, Alger JR, Di Salle F, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke. 1999;30:1174-1180.
10. Rovira A, Rovira-Gols A, Pedraza S, et al. Diffusion-weighted MR imaging in the acute phase of transient ischemic attacks. AJNR Am J Neuroradiol. 2002;23:77-83.
11. Davalos A, Matias-Guiu J, Torrent O, et al. Computed tomography in reversible ischaemic attacks: clinical and prognostic correlations in a prospective study. J Neurol. 1988;235:155-158.
12. Dennis M, Bamford J, Sandercock P, et al. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke. 1990;21:848-853.
13. Bamford J. Assessment and investigation of stroke and transient ischaemic attack. J Neurol Neurosurg Psychiatry. 2001;70(Suppl 1):13-16.
14. Caplan LR. Lice, fleas, and strokes. Arch Neurol. 2000;57:1113-1114.
15. Kraaijeveld CL, van Gijn J, Schouten HJ, et al. Interobserver agreement for the diagnosis of transient ischemic attacks. Stroke. 1984;15:723-725.
16. Ferra JM, Falcao I, Rodrigues G, et al. Diagnosis of transient ischemic attack by the nonneurologist: a validation study. Stroke. 1996;27:2225-2229.
17. Martin PJ, Young G, Enevoldson TP, et al. Overdiagnosis of TIA and minor stroke: experience at a regional neurovascular clinic. QJM. 1997;90:759-763.
18. Schulz UG, Rothwell PM. Transient ischaemic attacks mimicking focal motor seizures. Postgrad Med J. 2002;78:246-247.
19. Landi G. Clinical diagnosis of transient ischaemic attacks. Lancet 1992;339:402-405.
20. Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand. 1995;91:43-48.
21. Benavente O, Eliasziw M, Streifler JY, et al. Prognosis after transient monocular blindness associated with carotid-artery stenosis. N Engl J Med. 2001;345:1084-1090.
22. Flemming KD, Brown RD. Cerebral infarction and transient ischemic attacks. Postgrad Med. 2000;107:55-81.
23. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55:1649-1655.
24. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
25. Elkins JS, Sidney S, Gress DR, et al. Electrocardiographic indings predict short-term cardiac morbidity after transient ischemic attack. Arch Neurol. 2002;59:1437-1441.
26. Hori T, Terai S, Miake S, et al. [Diffusion MRI for evaluating TIA: a case of reversible ischemic injury in the territory of the deep perforators]. Rinsho Shinkeigaku. 1999;39:560-564.
27. Kidwell CS, Saver JL, Villablanca JP, et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke. 2002;33:95-98.
28. Douglas VC, Johnston CM, Elkins J, et al. Haad computed tomography findings predict short-term stroke risk after transient ischemic attack. Stroke. 2003;34:2894-2898.
29. Culebras A, Kase CS, Masdeu JC, et al. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke: a report of the Stroke Council, American Heart Association. Stroke. 1997;28:1480-1497.
30. Johnston SC. Clinical practice: transient ischemic attack. N Engl J Med. 2002;347:1687-1692.
31. Wardlaw JM. Radiology of stroke. J Neurol Neurosurg Psychiatry. 2001;70(Suppl 1):17-11.
32. Schellinger PD, Jansen O, Fiebach JB, et al. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke. 1999;30:765-768.
33. Linfante I, Llinas RH, Caplan LR, et al. MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke. 1999;30:2263-2267.
34. Lecouvet FE, Duprez TP, Raymackers JM, et al. Resolution of early diffusion-weighted and FLAIR MRI abnormalities in a patient with TIA. Neurology. 1999;52:1085-1087.
35. Crisostomo RA, Garcia MM, Tong DC. Detection of diffusion-weighted MRI abnormalities in patients with transient ischemic attack: correlation with clinical characteristics. Stroke. 2003;34:932-937.
36. Marx JJ, Mike-Gruettner A, Thoemke F, et al. Diffusion weighted magnetic resonance imaging in the diagnosis of reversible ischaemic deficits of the brainstem. J Neurol Neurosurg Psychiatry. 2002;72:572-575.
37. Kimura K, Minematsu K, Wada K, et al. Lesions visualized by contrast-enhanced magnetic resonance imaging in transient ischemic attacks. J Neurol Sci. 2000;173:103-108.
38. Schulz UG, Briley D, Meagher T, et al. Abnormalities on diffusion weighted magnetic resonance imaging performed several weeks after a minor stroke or transient ischaemic attack. J Neurol Neurosurg Psychiatry. 2003;74:734-738.
39. Brown RD Jr, Evans BA, Wiebers DO, et al. Transient ischemic attack and minor ischemic stroke: an algorithm for evaluation and treatment: Mayo Clinic Division of Cerebrovascular Diseases. Mayo Clin Proc. 1994;69:1027-1039.
40. Albers GW, Hart RG, Lutsep HL, et al. Addendum to the supplement to the guidelines for the management of transient ischemic attacks. Stroke. 2000;31:1001.
41. Leung DY, Black IW, Cranney GB, et al. Selection of patients for transesophageal echocardiography after stroke and systemic embolic events: role of transthoracic echocardiography. Stroke. 1995;26:1820-1824.
42. Cabral S, Oliveira F, Pereira S, et al. Transesophageal echocardiography in the assessment of patients presenting with ischemic cerebral events without previous evidence of a cardiac source of emboli. Rev Port Cardiol. 2001;20:247-258.
43. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med. 1991;325:1261-1266.
44. UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. BMJ. 1988;296:316-320.
45. Cerebral Embolism Task Force. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol. 1989;46:727-743.
46. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986;43:71-84.
47. Palacio S, Hart RG. Neurologic manifestations of cardiogenic embolism: an update. Neurol Clin. 2002;20:179-193, vii.
48. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack: French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J. 1995;130:1083-1088.
49. Stein PD. Antithrombotic therapy in valvular heart disease. Clin Geriatr Med. 2001;17:163-172, viii.
50. Scott PA, Barsan WG. Cerebrovascular disease. In: Harwood-Nuss A, ed. The Clinical Practice of Emergency Medicine. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:983-995.
51. Borg KT, Pancioli AM. Transient ischemic attacks: an emergency medicine approach. Emerg Med Clin North Am. 2002;20:597-608.
52. Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neurol Neurosurg Psychiatry. 1992;55:640-652.
53. Wilson SE, Mayberg MR, Yatsu F, et al. Crescendo transient ischemic attacks: A surgical imperative: veterans Affairs trialists. J Vasc Surg. 1993;17:249-255.
54. Fisher MC. Perspective: transient ischemic attacks. N Engl J Med. 2002;347:1642-1643.
55. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
56. Puranen J, Laakso M, Riekkinen P Sr, et al. Risk factors and antiplatelet therapy in TIA and stroke patients. J Neurol Sci. 1998;154:200-204.
57. Sivenius J, Riekkinen PJ Sr, Laakso M. Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes. BMJ. 1995;310:25-26.
58. Warlow C, Wardlaw J. The drug trials that have influenced our clinical practice in acute ischaemic stroke. Thromb Haemost. 1997;78:558-561.
59. Albers GW, Hart RG, Lutsep HL, et al. AHA Scientific Statement. Supplement to the guidelines for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks, Stroke Council, American Heart Association. Stroke. 1999;30:2502-2511.
60. Albers GW, Easton JD, Sacco RL, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 1998;114(5 Suppl):683S-698S.
61. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 2001;119(1 Suppl):300S-320S.
62. The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet. 1991;338:1345-1349.
63. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
64. Sivenius J, Riekkinen PJ, Kilpeleinen H, et al. Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS). Acta Neurol Scand. 1991;84:288-290.
65. Bellavance A. Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events: the Ticlopidine Aspirin Stroke Study. Stroke. 1993;24:1452-1457.
66. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
67. Brott T, Clark W, Fagan S, et al. Stroke: The First Hours: Guidelines for Acute Treatment. Englewood, CO: National Stroke Association; 2000.
68. Liu M, Counsell C, Sandercock P. Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2000:CD000248.
69. Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444-1451.
70. Algra A, de Schryver EL, van Gijn J, et al. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Cochrane Database Syst Rev. 2001;4:CD0001342.
71. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet. 1993;342:1255-1262.
72. Al-Sadat A, Sunbulli M, Chaturvedi S. Use of intravenous heparin by North American neurologists: do the data matter? Stroke. 2002;33:1574-1577.
73. Mayberg MR, Wilson SE, Yatsu F, et al. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stanosis: Veterans Affairs Cooperative Studies Program 309 Trialist Group. JAMA. 1991;266:3289-3294.
74. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;339:1415-1425.
75. North Amarican Symptomatic Carotid Endarterectomy Trial (NASCET) Investigators. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery: National Institute of Neurological Disorders and Stroke, Stroke and Trauma Division. Stroke. 1991;22:816-817.
76. Randomised trial of endarterectomy for recently symptomatic results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
77. Streifler JY, Eliasziw M, Benavente OR, et al. The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol. 1995;52:246-249.
78. Hobson RW 2nd. CREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status. Semin Vasc Surg. 2000;13:139-143.
79. Chang E, Holroyd BR, Kochanski P, et al. Adherence to practice guidelines for transient ischemic attacks in an emergency department. Can J Neurol Sci. 2002;29:358-363.
80. Edlow JA. United States emergency department visits for TIA: a national study from 1992-2000. Presented at: Society for Academic Emergency Medicine national conference; May 2003; Boston, MA.
81. Asimos A. Code stroke: a state-of-the-art strategy for rapid assessment and treatment. Emerg Med Practice. 1999;1:1-24.